Skip to content
Sandra Ortiz-Cuaran· @SandraOrtizCua1 · X·· 2026-04-21Score60
Body

A timely and comprehensive review from the
@AACR
Lung Cancer Task Force is out, in parallel to #AACR26.

Understanding the biology of treatment-persistent residual disease to overcome treatment #resistance is delineated as one of such priorities.
#LCSM

https://
aacrjournals.org/cancerdiscover
y/article/doi/10.1158/2159-8290.CD-25-2318/783960/A-Roadmap-to-Transform-Lung-Cancer-Outcomes
…

Heat 10 · 6 likes · 0 replies · 4 reposts

Source: Sandra Ortiz-Cuaran · x.com

CBACBA Frontier Insights (CFI)Chinese Biopharmaceutical Association (CBA)www.cba-usa.org